Explore more publications!

Falkland Islands Science Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Falkland Islands Science Times.

Press releases published on December 3, 2025

Seismic Protection Device Market to Reach USD $3.96 Billion by 2029 at 6.6% CAGR
Semiconductor Contract Manufacturing Market 2025-2029: Unveiling Growth Developments with the Latest Updates
Serverless Data Processing Market: Future Demand and Top Key Players Analysis | 2029
Shared Desk Market - Opportunities, Share, Growth and Competitive Analysis and Forecast 2029
Telecom Network Automation Industry Report: Competitive Landscape and Future Prospects
Orezone Intercepts 3.28 g/t Gold Over 26.00m and 5.55 g/t Gold Over 15.00m at P17 Zone in Advance of Hard Rock First Gold
The New England Journal of Medicine Publishes Positive Phase 3 VALIANT Results of EMPAVELI® (pegcetacoplan) for C3G and Primary IC-MPGN
Descartes Announces Fiscal 2026 Third Quarter Financial Results
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
NowVertical Promotes Christine Nelson to Permanent Chief Financial Officer
MKS Inc. Named One of America’s Most Responsible Companies
reAlpha (NASDAQ: AIRE) Appoints Thomas Kutzman to Lead Brokerage Division as CEO of reAlpha Realty
Real-Time Vector Search Gateways Market Expanding With $5.8 Billion at 29.1% CAGR by 2029
Reconfigurable Optical Add-Drop Multiplexer (ROADM) Module Market to Expand at a 14.1% CAGR by 2029, Reaching US $4.2 Bn
Innventure to Participate in Upcoming Investor Conferences
JMU experts available to provide essential holiday tips
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual Conference
Soleno Therapeutics Announces the Passing of Board Member William G. Harris
TScan Therapeutics to Host Virtual KOL Event to Discuss Clinical Updates from the ALLOHA™ Phase 1 Trial and Future Market Opportunities

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions